U.S., June 6 -- ClinicalTrials.gov registry received information related to the study (NCT07007260) titled 'Effect of Niacinamide Supplementation in Glaucoma' on Jan. 13.
Brief Summary: Niacinamide is a chemical derivative of niacin, also known as vitamin B3. Through its complex role in the energetic metabolism, it has been evaluated and proven useful in several neurodegenerative disorders, such as Alzheimer's disease. Its effect in glaucoma, an optic nerve disorder related to a high intraocular pressure, is not well defined, and requires more research.
The investigators aim to assess the physiological effects of niacinamide on specific markers (e.g., visual field parameters, retinal nerve fibre layer thickness, electrophysiological marke...